Serious Health Risks Associated With Prostate Cancer Treatment
January 26, 2009 by Bob Livingston
Conventional medicine aggressively attacks prostate cancer with androgen blockade or androgen deprivation.
In humans (predominantly males), the major androgen is testosterone. Natural testosterone is an elixir of life. It rises in youth (predominately males) to about age 25, and then it begins to decline. Researchers claim that aging and deterioration of health occurs with declining testosterone.
Natural testosterone, not to be confused with synthetic steroid drugs, “has been scientifically shown to enhance sexuality, vitality, cardiovascular health and general health.” (From the book, Maximize Your Vitality and Potency for Men Over 40 by Jonathan Wright, M.D. and Lane Lenard, Ph.D.)
Conventional medicine, sometimes referred to as “orthodox medicine,” hatched this “androgen blockade” as a procedure in cancer treatment usually followed by a prostate operation leaving most men impotent, along with other serious complications. Well, you know the story. It has a monotonously fatal ring to it.
Now researchers say that cardiovascular mortality, in some cases, follows androgen deprivation (blockade) and that it is associated with a greater risk of coronary artery disease, myocardial infarction and diabetes.
Prostate doctors are loose with their prostate cancer patients, as well as all prostate patients with high prostate specific antigen (PSA) measurements.
Before any man agrees to androgen blockade or a prostate operation, they should read Jonathan Wright’s book, Maximize Your Vitality and Potency for Men Over 40.
Testosterone is nature’s answer for vitality, health and longevity.
I personally use 5 percent testosterone by prescription from a compounding pharmacy. Women need about one-tenth as much testosterone as men, but they do need it.